DASH vs HAE · P/E 76, rev $13.72B vs P/E 35, rev $1.36B
DoorDash, Inc. Class A Common Stock (DASH) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the DASH and HAE stock pages for the full models.
Not investment advice.